Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3517 | 997 | 28.8 | 44% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
316 | 35223 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//SGLT2 INHIBITOR |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
21741 | 350 | SERUM MEDIATORS//LY2216684//NEPHROLOGY CLINICAL PRACTICE GUIDELINES |
24416 | 261 | AMINO ACID LOAD//GALLBLADDER OPACIFICATION//P AMINOHIPPURATE TRANSPORT |
26793 | 201 | CLONIC CONVULSION//INDUCED SEIZURES//BEMEGRIDE |
31953 | 115 | BENZARONE//BENZBROMARONE//EQUATORIAL CONFORMATION |
34475 | 70 | APA HAMSTER//APA HAMSTERS//ATHEROMATOUS LESION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | APA HAMSTER | Author keyword | 9 | 64% | 1% | 9 |
2 | APA HAMSTERS | Author keyword | 8 | 75% | 1% | 6 |
3 | AMINO ACID LOAD | Author keyword | 5 | 63% | 1% | 5 |
4 | GALLBLADDER OPACIFICATION | Author keyword | 4 | 75% | 0% | 3 |
5 | SERUM MEDIATORS | Author keyword | 4 | 75% | 0% | 3 |
6 | LY2216684 | Author keyword | 3 | 100% | 0% | 3 |
7 | NEPHROLOGY CLINICAL PRACTICE GUIDELINES | Author keyword | 3 | 100% | 0% | 3 |
8 | UREMIC SERUM | Author keyword | 3 | 50% | 0% | 4 |
9 | EDIVOXETINE | Author keyword | 3 | 60% | 0% | 3 |
10 | P AMINOHIPPURATE TRANSPORT | Author keyword | 3 | 42% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | APA HAMSTER | 9 | 64% | 1% | 9 | Search APA+HAMSTER | Search APA+HAMSTER |
2 | APA HAMSTERS | 8 | 75% | 1% | 6 | Search APA+HAMSTERS | Search APA+HAMSTERS |
3 | AMINO ACID LOAD | 5 | 63% | 1% | 5 | Search AMINO+ACID+LOAD | Search AMINO+ACID+LOAD |
4 | GALLBLADDER OPACIFICATION | 4 | 75% | 0% | 3 | Search GALLBLADDER+OPACIFICATION | Search GALLBLADDER+OPACIFICATION |
5 | SERUM MEDIATORS | 4 | 75% | 0% | 3 | Search SERUM+MEDIATORS | Search SERUM+MEDIATORS |
6 | LY2216684 | 3 | 100% | 0% | 3 | Search LY2216684 | Search LY2216684 |
7 | NEPHROLOGY CLINICAL PRACTICE GUIDELINES | 3 | 100% | 0% | 3 | Search NEPHROLOGY+CLINICAL+PRACTICE+GUIDELINES | Search NEPHROLOGY+CLINICAL+PRACTICE+GUIDELINES |
8 | UREMIC SERUM | 3 | 50% | 0% | 4 | Search UREMIC+SERUM | Search UREMIC+SERUM |
9 | EDIVOXETINE | 3 | 60% | 0% | 3 | Search EDIVOXETINE | Search EDIVOXETINE |
10 | P AMINOHIPPURATE TRANSPORT | 3 | 42% | 1% | 5 | Search P+AMINOHIPPURATE+TRANSPORT | Search P+AMINOHIPPURATE+TRANSPORT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | L PROPRANOLOL | 33 | 100% | 1% | 13 |
2 | PHENOBARBITAL CONCENTRATIONS | 8 | 62% | 1% | 8 |
3 | AMBULATORY HEMODIALYSIS PATIENTS | 7 | 53% | 1% | 10 |
4 | DISEASE STATES | 6 | 21% | 2% | 23 |
5 | HEPATIC CYTOCHROME P450 | 3 | 12% | 2% | 21 |
6 | RIGHTING REFLEX | 3 | 22% | 1% | 11 |
7 | DRUG RELATED PROBLEMS | 3 | 15% | 2% | 17 |
8 | DRUG ACTION | 2 | 10% | 2% | 20 |
9 | DOSAGE ADJUSTMENTS | 2 | 67% | 0% | 2 |
10 | IMPLEMENTED ANEMIA MANAGEMENT | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport | 2014 | 16 | 49 | 59% |
The effect of chronic renal failure on drug metabolism and transport | 2008 | 55 | 63 | 57% |
Drug-related problem in children with chronic kidney disease | 2013 | 6 | 22 | 45% |
Consequences of Renal Failure on Non-Renal Clearance of Drugs | 2014 | 4 | 88 | 57% |
Emerging Areas of Research in the Assessment of Pharmacokinetics in Patients With Chronic Kidney Disease | 2015 | 1 | 41 | 12% |
Altered nonrenal drug clearance in ESRD | 2008 | 28 | 43 | 51% |
Polypharmacy and medication-related complications in the chronic kidney disease patient | 2011 | 7 | 10 | 60% |
The effect of chronic renal failure on hepatic drug metabolism and drug disposition | 2003 | 58 | 40 | 40% |
Pharmacokinetics and dosage adjustment in patients with renal dysfunction | 2009 | 63 | 100 | 26% |
THE EFFECT OF RENAL-FAILURE ON HEPATIC DRUG CLEARANCE | 1991 | 75 | 50 | 26% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN PHARM PROGRAMME | 1 | 50% | 0.2% | 2 |
2 | CENT SUPPORT SERV | 1 | 50% | 0.1% | 1 |
3 | CLIN PHARM IQ HEALTHCARE | 1 | 50% | 0.1% | 1 |
4 | E HLTH STRATEG IT | 1 | 50% | 0.1% | 1 |
5 | EPHE PHYSIOL | 1 | 50% | 0.1% | 1 |
6 | MED E FAMILY PRACTICE IDENCY PROGRAM | 1 | 50% | 0.1% | 1 |
7 | NONCLIN SAFETY PRNS | 1 | 50% | 0.1% | 1 |
8 | SANOFI AVENTIS ENDOWMENT CHAIR AMBULATORY PHARMA | 1 | 50% | 0.1% | 1 |
9 | VIA SERGIO PANSINI 5 | 1 | 50% | 0.1% | 1 |
10 | SANOFI AVENTIS ENDOWMENT CHAIR AMBULATORY PHARMAC | 1 | 25% | 0.2% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000018925 | PEPT1//PEPT2//HPEPT1 |
2 | 0.0000018204 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
3 | 0.0000013344 | MICROALBUMINURIA//GLOMERULAR FILTRATION RATE//CYSTATIN C |
4 | 0.0000012576 | BEERS CRITERIA//PHARMACOVIGILANCE//MEDICATION RECONCILIATION |
5 | 0.0000009573 | GENTAMICIN//WEN PI TANG//GENTAMICIN INDUCED NEPHROTOXICITY |
6 | 0.0000009490 | HEMODIALYSIS//BLOOD PURIFICATION//HAEMODIALYSIS |
7 | 0.0000008539 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//AMERICAN JOURNAL OF HOSPITAL PHARMACY//COMMUNITY PHARMACY |
8 | 0.0000007364 | TORASEMIDE//HYPERKALEMIA//FUROSEMIDE |
9 | 0.0000007050 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
10 | 0.0000006493 | BILE ACIDS//FARNESOID X RECEPTOR//CEREBROTENDINOUS XANTHOMATOSIS |